Anbieter: Biblioteca di Babele, Tarquinia, VT, Italien
Zustand: OTTIMO USATO. ITALIANO IL LIBRO È USATO, PERTANTO POTREBBE PRESENTARE LIEVI DIFETTI/IMPERFEZIONI. LA FOTO CORRISPONDE AL LIBRO IN VENDITA. Perché l'Italia è esclusa dal grande business della farmaceutica mondiale. Chi ha spinto il paese fuori dal gotha della ricerca scientifica e dalla modernità, e perché tutto questo ci impoverisce e fa male alla salute. Montedison, farmitalia, i centri di ricerca sul cancro. Interessi politici, mazzette e tanto spreco. Uno dei capitoli più controversi della recente storia italiana. Prefazione di Ignazio Marino Numero pagine XVIII-293. Il copyright dei dati è di Informazioni Editoriali I.E. Srl.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,43
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1990
ISBN 10: 3540522972 ISBN 13: 9783540522973
Anbieter: moluna, Greven, Deutschland
EUR 92,27
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 150,45
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. illustrated edition. 100 pages. 10.91x8.27x0.24 inches. In Stock.
Taschenbuch. Zustand: Neu. The Management of Non-Hodgkin's Lymphomas in Europe | Silvio Monfardini | Taschenbuch | viii | Englisch | 1990 | Springer | EAN 9783540522973 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 1990
ISBN 10: 3540522972 ISBN 13: 9783540522973
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and its seminars on new techniques or on the principal therapeutic controversies, it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the Uni versity and Industry and between these two and daily medical practice. One of the more recent initiatives of the ESO is the Intercity Meetings. The concept of Inter city Meetings was first put forward with the idea of creating total coverage throughout Europe of certain tumours at the forefront of research and, in some cases, controversy.